Suppr超能文献

血浆冻融对内源性止血的激活作用。

Intrinsic hemostasis activation by freezing and thawing of plasma.

作者信息

Stief Thomas W, Otto Stefanie, Renz Harald

机构信息

Department of Clinical Chemistry, University Hospital Giessen & Marburg, Germany.

出版信息

Clin Appl Thromb Hemost. 2009 Feb;15(1):59-64. doi: 10.1177/1076029607303763.

Abstract

Low-grade contact activation of hemostasis is clinically relevant. Freezing/thawing of plasma was studied in the intrinsic coagulation activity assay. Normal plasmas were frozen at -80 degrees C or -20 degrees C and thawed at 37 degrees C or 23 degrees C. These plasmas and unfrozen samples were activated by SiO2 -CaCl2. Freezing/thawing of normal plasma induced about 100-fold more thrombin activity at 5 minutes coagulation reaction time than the respective unfrozen samples. Freezing at -80 degrees C induces more artificial changes than freezing at -20 degrees C. In 9 of 10 plasmas of patients receiving coumarin, nearly no additional thrombin is generated within a 12-minute coagulation reaction time. Minor procoagulant changes of plasma might be dangerous in patients with insufficient liver function, who might not tolerate a therapy with fresh frozen plasma, which behaves as a procoagulant because of its matrix changes. The intrinsic coagulation activity assay allows the measurement of low-grade contact activation of frozen/thawed plasma.

摘要

低级别止血接触激活具有临床相关性。在凝血内源性活性测定中研究了血浆的冻融情况。正常血浆在-80℃或-20℃冷冻,并在37℃或23℃解冻。这些血浆和未冷冻样本用二氧化硅-氯化钙激活。在5分钟凝血反应时间时,正常血浆的冻融诱导的凝血酶活性比相应未冷冻样本高约100倍。-80℃冷冻比-20℃冷冻诱导更多人为变化。在接受香豆素治疗患者的10份血浆中,有9份在12分钟凝血反应时间内几乎不产生额外凝血酶。血浆轻微的促凝变化在肝功能不全患者中可能是危险的,这些患者可能无法耐受新鲜冰冻血浆治疗,因为新鲜冰冻血浆由于其基质变化而表现为促凝剂。凝血内源性活性测定可用于测量冻融血浆的低级别接触激活。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验